AstraZeneca PLC - SWOT Analysis
Datamonitor's AstraZeneca PLC - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
AstraZeneca was formed in 1999 by the merger of Swedish-based Astra AB and UK-based Zeneca Group Plc. The company is the second largest UK pharmaceutical player (behind GlaxoSmithKline) and is headquartered in London. AstraZeneca has a strong presence in the US and retains a significant presence in Sweden as a legacy of Astra AB. The publicly run company employs around 66,000 people worldwide. The company recorded revenues of $26,475 million during the fiscal year ended December 2006, an increase of 10.5% over 2005. The operating profit of the company was $8,216 million during fiscal year 2006, an increase of 26.4% over 2005. The net profit was $6,043 million in fiscal year 2006, an increase of 28.4% over 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
RELATED REPORTS
Datamonitor's Amylin Pharmaceuticals Inc - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and st ...
Datamonitor's CuraGen Corporation - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ...
Public healthcare programs reimburse costs for majority of dialysis treatments in the United States and in Western Europe. The governments of these regions are considering proposals for controlling costs by altering the public-sponsored healthcare programs. This move is likely to change the profita ...
Industries : Medical Devices, Pathology, Healthcare | Countries : USA
The market for hypertensives - led by the angiotensin II antagonists - is one of the largest and most profitable in the global pharmaceutical market, with total anti-hypertensive sales of $36600m in 2006. Hypertension, or high blood pressure, is a worldwide epidemic: by 2025 visiongain predict that ...
Diabetes affects approximately 246 million people worldwide and this number is increasing. The IDF predict 380 million diabetics by 2025. The Global Diabetes drug treatment market was valued at over $21 billion in 2006 and the market is still expanding rapidly due to the high prevalence of diabetes ...
Datamonitor's Eli Lilly and Company - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy ...
Vaccine manufacturers from all over the world have been involved in a stalemate with governments regarding supply and demand. While governments are reluctant to ensure steady demand for vaccines unless the manufacturers can prove their ability to increase their supply, the latter are apprehensive a ...
In this report, now available in English for the first time, MSI analyses the Spanish personal protective equipment market for a five-year review period (2003-2007) and a five year forecast period up until 2012. Our regular clients asked us to produce an English version of our detailed market study, ...
Industries : Clothing Accessories, Security Services, Pathology, Clothing and Textile | Countries : USA, Spain, United Kingdom
Pet Insurance in North America, 3rd Edition If the future of this market depends on marketing-driven consumer demand, as Packaged Facts believes it does and history supports, then the North American market for pet insurance is at a pivotal stage. Since the previous edition of this report, published ...
Industries : Wireless Technology, Pathology, Health Insurance, Pharmaceutical | Countries : Canada, USA
Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2007 and 2008. Since Kalorama Information last updated Kalorama Information's The World Market for Vaccines in the first quarter of last year, new products and better than expected p ...
Related industries
reportlinker.com © Copyright 2009. All rights reserved